Highlights the importance of integrating palliative care into the management of Stage D heart failure through collaboration between cardiology and palliative specialists.
Answers are grounded in this paper and cite their sources.
Supports palliative integration in Stage D HF; leaves open optimal models pending prospective trials.
Heart failure is the major cause of morbidity and mortality in the United States. Stage D heart failure has a greater mortality rate than many cancers and has equivalent symptom burden and severity. There has been a paradigm shift in our understanding of the pathophysiology of heart failure. Progressive heart failure is associated with ventricular remodeling and a maladaptive neurohumoral response. Drug classes have evolved that curtail ventricular remodeling, and blunt neurohumoral responses reduce morbidity and mortality. Despite combination drug and device therapies, the management of Stage D heart failure includes palliation. Both cardiology and palliative specialists need to learn from one another in order to palliate these highly symptomatic patients. Such collaboration will enhance care and are the basis for well-conceived research trials.
No takes yet. Share an insight, caveat, or question.
Davis et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: